摘要
目的了解孟鲁司特联合吸入布地奈德治疗重度哮喘的疗效。方法孟鲁司特联合吸入布地奈德治疗30例重度哮喘患者,根据纳入和排除标准筛选病例,据疗效判断标准进行临床疗效的判断。结果孟鲁司特联合吸入布地奈德治疗30例重度哮喘6周后,治疗前早、晚间PEF,治疗前早、晚间喘乐宁气雾剂喷数,治疗前日、夜间哮喘症状评分和治疗后相比具有显著性差异(P<0.01)。结论孟鲁司特联合吸入布地奈德治疗重度哮喘有效。
Objective To study the clinical efficacy of montelukast associated with budesonide on severe asthma patients. Methods According to the inclusion and exclusion criteria, 30 severe asthma patients were involved in the present trial, and received six weeks＇treatment. The clinical efficacy of the combined therapy was observed. Results There was significant amelioration concerning the peak expiratory flow （PEF）, the puff number of the salbutamol, and the score of the asthma symptom of the day and night after six weeks＇treatment （P 〈 0.01）. Conclusion Montelukast associated with budesonide can be used to treat severe asthma effectively
出处
《实用临床医药杂志》
CAS
2006年第6期47-49,58,共4页
Journal of Clinical Medicine in Practice
